Technical Analysis for ACST - Acasti Pharma, Inc.
|Grade||Last Price||% Change||Price Change|
ACST closed unchanged on Friday, February 16, 2018, on 18 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
|Weak or Absent||Down||Down||Down|
|See historical ACST trend table...|
|Date||Alert Name||Type||% Chg|
|Feb 16||Narrow Range Bar||Range Contraction||0.00%|
|Feb 16||NR7||Range Contraction||0.00%|
|Feb 16||NR7-2||Range Contraction||0.00%|
|Feb 16||Wide Bands||Range Expansion||0.00%|
|Feb 15||Narrow Range Bar||Range Contraction||0.00%|
|Feb 15||NR7||Range Contraction||0.00%|
|Feb 15||Wide Bands||Range Expansion||0.00%|
|Feb 14||Non-ADX 1,2,3,4 Bearish||Bearish Swing Setup||-0.95%|
|Feb 14||Wide Bands||Range Expansion||-0.95%|
|Feb 13||MACD Bullish Signal Line Cross||Bullish||-2.80%|
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of new therapies for abnormalities in blood lipids, and the treatment and prevention of cardiovascular disorders. The company offers Onemia, a medical food that is used in the dietary management of illnesses associated with omega-3 phospholipids deficiency related to cardiometabolic disorders. Its product development pipeline includes CaPre, a drug product candidate that is in Phase II clinical trial for the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada. Acasti Pharma Inc. is a subsidiary of Neptune Technologies & Bioressources Inc.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more ACST news...
|52 Week High||3.36|
|52 Week Low||0.84|
|200-Day Moving Average||1.2897|
|50-Day Moving Average||1.1234|
|20-Day Moving Average||1.0925|
|10-Day Moving Average||1.046|
|Average True Range||0.0795|
|Chandelier Exit (Long, 3 ATRs )||1.0615|
|Chandelier Exit (Short, 3 ATRs )||1.2085|
|Upper Bollinger Band||1.2229|
|Lower Bollinger Band||0.9621|
|Percent B (%b)||0.3|
|MACD Signal Line||-0.0255|
|Market Cap||15.3 Million|
|Num Shares||14.7 Million|
|Price-to-Earnings (P/E) Ratio||-1.35|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||1.08|
|Resistance 3 (R3)||1.08||1.07||1.08|
|Resistance 2 (R2)||1.07||1.06||1.07||1.07|
|Resistance 1 (R1)||1.05||1.05||1.05||1.05||1.07|
|Support 1 (S1)||1.02||1.03||1.03||1.03||1.01|
|Support 2 (S2)||1.01||1.02||1.01||1.01|
|Support 3 (S3)||0.99||1.01||1.00|
|Support 4 (S4)||1.00|